Has Dennis Birenbaum received payments from drug or device companies?

Yes. Drug and device makers reported $6,442 in general payments to Dennis Birenbaum across 304 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dennis Birenbaum did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dennis Birenbaum come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dennis Birenbaum

Hematology & Oncology · Dallas, TXNPI 1538119045

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,795 of the $6,442 with a category attached, or 74.4%. 48 manufacturers reported payments, led by Novartis at 25.8% of the total. Reporting peaked in 2021 at $2,294 and has fallen 53.3% since, to $1,071 in 2022.

$6,442in general payments, 2019–2025

Across 304 payments — averaging $21.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$2K
Incyte Corporation$553
Pfizer$533
Merck$348
Johnson & Johnson$346
Eisai Inc.$343
plus $3K from 42 others

$18,931in research payments, 2019–2025

Across 3 payments — averaging $6310.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Daiichi Sankyo Inc.$16K
Amgen$3K

What the payments were for

Food & beverage$4,79574%
Education$69911%
Other$94815%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	55	$1,660
Incyte Corporation	22	$553
Pfizer	40	$533
Merck	20	$348
Johnson & Johnson(2 entities)	13	$346
Eisai Inc.	17	$343
Amgen	11	$272
Gilead(2 entities)	11	$242
AstraZeneca	10	$172
E.r. Squibb & Sons, L.L.C.	10	$163
Takeda Pharmaceuticals U.S.A., Inc.	7	$153
Lexicon Pharmaceuticals, Inc.	8	$118
Dova Pharmaceuticals	7	$111
Taiho Oncology, Inc.	7	$108
EMD Serono, Inc.	6	$105
Astellas Pharma US Inc	5	$96
Acrotech Biopharma Inc.	3	$88
Octapharma USA, Inc.	2	$78
Genentech USA, Inc.	4	$75
Sun Pharmaceutical Industries Inc.	3	$68
Blueprint Medicines Corporation	3	$54
Pharmacyclics LLC, An Abbvie Company	3	$50
Sanofi	3	$50
Regeneron Healthcare Solutions, Inc.	2	$50
Foundation Medicine, Inc.	2	$45
AMAG Pharmaceuticals, Inc.	2	$39
Bristol Myers Squibb	2	$39
GSK	2	$36
Sirtex Medical Inc	2	$35
Exelixis Inc.	2	$34
Clovis Oncology, Inc.	2	$32
Array Biopharma Inc	2	$31
Ipsen Biopharmaceuticals, Inc	1	$26
Deciphera Pharmaceuticals Inc.	1	$25
Global Blood Therapeutics, Inc.	1	$25
Daiichi Sankyo Inc.	1	$25
Myovant Sciences Inc.	1	$24
Coherus Oncology, Inc.	1	$23
Acceleron Pharma, Inc.	1	$22
Advanced Accelerator Applications	1	$21
Bayer	1	$19
Karyopharm Therapeutics Inc.	1	$18
EUSA Pharma (US) LLC	1	$18
Alnylam Pharmaceuticals Inc.	1	$16
Helsinn Therapeutics (U.S.), Inc.	1	$15
Rigel Pharmaceuticals, Inc.	1	$15
Tactile Systems Technology Inc	1	$12
Epizyme, Inc.	1	$11

How this compares

$6,442 in reported general payments places this provider in the 60th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas →

Other hematology & oncology in Dallas

Edward PearsonDallas$900K
Christopher MaiselDallas$713K
Ashwani AgarwalDallas$275K
Katherine WangDallas$188K
Houston HolmesDallas$178K
Benjamin KitchensDallas$177K
Farrukh AwanDallas$138K
Dai Chu LuuDallas$90K
Luis PineiroDallas$86K
Joan SchillerDallas$85K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →